Usman Ghani is seeking a CRA position and has over 10 years of experience in healthcare and clinical research. He has experience as a study coordinator and CRA in various therapeutic areas in the US and Pakistan. His responsibilities included monitoring visits, data verification, query resolution, training sites, and ensuring protocol and regulatory compliance. He is ICH GCP and FDA regulation certified and has a medical degree from Frontier Medical School in Pakistan.
Global Clinical Trials: Best Practices & Common PitfallsImperial CRS
45% of clinical trials are conducted exclusively in non-U.S. countries, and only 6% are registered in both the U.S. and rest of the world. The globalization of clinical trials demands deeper knowledge and greater efficiencies in planning and execution. In our inaugural webinar, Melynda Geurts, Dan McDonald, and Gwen Welty of DAC Patient Recruitment Services explore actionable solutions to real-world multinational trial challenges, including:
Protocol Design
Regulatory Planning
Local Expertise and Logistics
Study Feasibility
Investigator Relations
Recruitment and Retention
FOR MORE INFORMATION, VISIT WWW.IMPERIALCRS.COM
I am writing in regards to the Clinical Research Associate position that is open with your company at this time. I am an experienced CRA with over three years in clinical trials with broad background in clinical trials management of Phase II/III trials in various indications including the implementation of study protocols, monitoring of study sites and on-site data management and collection of study-related documents. With excellent organizational skills and a profound background of working in a managerial capacity, along with my ability to learn rapidly and proficiently, will allow me to be a valuable part of your team as well as contribute to your constant success.
• Responsible for identifying the comprehensive legal patient medical record in paper and electronic systems in Health Information.
• Duties include assuring all patient records and loose documents are scanned and indexed into the EPF with the highest level of quality possible.
• Responsible for full range of tasks performed in health information department with regard to health information management and maintenance.
• Provides customer service support of the health information department and any other duties assigned.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Usman ghani resume
1. USMAN GHANI (M.D)
9467 w Longview pkwy Kansas City, MO 64138
913-523-5414 (cell)
usmanghani1984@aol.com
Willing to relocate. Nearest airport MCI 38 mins away.
OBJECTIVE
Dependable and hard-working foreign country CRA-MD is seeking CRA position.
Highly motivated team player, with excellent organizational, interpersonal, verbal and
writing communication skills.
Strong attention to detail, functioning well under work demand, prioritizing and
recognizing timely work requirements.
Strongly interested in conducting research in an ethical and safe manner.
PROFESSIONAL EXPERIENCE
Study Coordinator: PSCHIATRY ASSOCIATE OF KANSAS CITY
(PAKC)2017-2018
EHRHARDT CLINICAL RESEARCH, BELTON, MO 2017
Performed duties of Study Coordinator in conducting 4 research studies of CNS
therapeutic areas, i.e. PPD, Depression, Tourette syndrome, TMS.
Entering patient records in EHR system, helped Sub-I and PI to develop Research center
in Kansas City region.
Developing ICF, and source documentation according to protocol, patient screening, I/E
criteria, labs collection and processing, phlebotomy, audit reports, patient visits, EDC
Data entry and query resolution, IRB submission and follow up, AE and SAE recording
and SAE submission to IRB, IMP accountability and re-ordering, communication with
Sponsor, CRO, and vendors.
CRA EXPIRIENCE:
Rx Pharmaceutical, LTD, Lahore, Pakistan-2010-2014
Therapeutic Areas:
Oncology, solid tumors-Phase II-III
Oncology liquid tumors-Phase III
Hepatitis-C-Phase III
Endocrinology/Diabetes mellitus Type II
GI-Gastro-enterology- Phase II
Cardio-vascular Phase III
2. Respiratory-Asthma and Allergy-Phase III
CNS/Depression, PPD-II-III
Responsibilities:
As a field CRA conducted all 4 different visits, i.e. Site Selection Visits-SSV, Site
initiation Visit-SIV, Routine Monitoring Visits-IMV, and Closing Visits-COV. In
addition, conducted multiple SWAT SSVs and co-monitoring visits
Responsibilities included but not limited to: Identifying and selecting sites for
participation, training site personnel on protocol during SIV, and re-training upon
necessity, conducting monitoring visit with 360 degrees data verification between source
documents and CRF, both paper and electronic, remote monitoring via EDC, queries
resolutions, working with study coordinators and PIs for clean and accurate data
submission, performing drug accountability as blinded monitor, monitoring SAEs and
assure timely submission to IRB, identified deviations to protocol and work with sites to
their resolutions, working with Data Management during data clean up, preparing sites
for Sponsor Audit, writing Confirmation letters, reports and follow up letters after each
visit, identifying site weak enrollment and performance issues, and supporting them for
successful improvement, review regulatory documents preferably during each IMV when
possible, work with sites to improve enrollment and retention numbers, submitting
documents to TMF, attending Investigator Meeting.
Timely completed required SOPs and training courses.
QUALIFICATION S
Highly motivated, dedicated, and detail-oriented professional with over 10 years of
healthcare experience including patient management at both in and out-patient facilities
and years of experience in conducting clinical research under PI/Sub-I supervision.
Driven by new challenges and desire to be successful, offers superior communication,
leadership, management and organization skills.
PROFESSIONAL STRENGTHS
ICH GCP
FDA REGULATION
IRBs
Data collection and processing, attention to detail
Clinical trials. Phase(s) II-III
Large group presentation
Team management
Superior communication skills
Cross-functions working capabilities
Great learning abilities
Medical terminology expert
US CERTIFICATION
3. NIH (National Institute of Health) Current
GCP (NIDA clinical trials) Current
EDUCATION
CLINICAL RESEARCH FASTRACK AZ, USA 2017, CRA
FRONTIER MEDICAL SCHOOL, Abbottabad, Pakistan
Bachelor of Medicine and Bachelor of Surgery, 2010 GPA:3.24
Conducting and assisting in Researchduring the years in Medical school.
PERSONAL ATTRIBUTES
Detail-oriented, timeline driven, good listener, eager and fast learner.
Excellent communication and client/vendor service skills.
Perform and travel well under tight and demanded schedule.
Perform well as an individual and team player, always keeping satisfactory goal
completion in mind.
Analytical and respectful, work well in multicultural settings.
SKILLS
EHR System, EDC, EMR
Microsoft Word, Microsoft Outlook
Microsoft Excel
Microsoft PowerPoint, Skype.
REFERENCES
Status: US Permanent Resident.
All Diplomas and Certificates are translated and evaluated in USA by WES, and
available upon request.
Professional references:
CJ Anderson (president at FINDING PHARMA) -Mentor (480)-355-5278.
Lauren Ballina - CCRC, NATIONAL DIRECTOR OF CLINICAL RESEARCH
FASTRACK AZ Instructor-Mentor (724)-575-2342
Jody Ehrhardt (CEO EHRHARDT CLINICAL RESEARCH BELTON, MO)
Supervisor (816)-405-6076
Dr Sherman Cole MD (913)-385-7252
Dr Dennis P. Owens MD (913)-385-7252
Personal Reference:
Vita Gredinberg, Sr. CRA-408-410-7876
4. Personal interests: Quality time with family and friends, outdoors, listening to classical
music, meditation. Non- smoking.
